155 related articles for article (PubMed ID: 37221131)
41. No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases.
Ota T; Amagai M; Watanabe M; Nishikawa T
J Dermatol Sci; 2003 Aug; 32(2):137-41. PubMed ID: 12850306
[TBL] [Abstract][Full Text] [Related]
42. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. clinical overview and pathophysiology.
Anderson HJ; Huang S; Lee JB
J Am Acad Dermatol; 2023 Aug; ():. PubMed ID: 37597771
[TBL] [Abstract][Full Text] [Related]
43. Detection of autoantibodies to periplakin and envoplakin in paraneoplastic pemphigus but not idiopathic pulmonary fibrosis using full-length recombinant proteins.
Muro Y; Sugiura K; Shiraki A; Ishii N; Hashimoto T; Akiyama M
Clin Chim Acta; 2014 Feb; 429():14-7. PubMed ID: 24275244
[TBL] [Abstract][Full Text] [Related]
44. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.
Wang J; Zhu X; Li R; Tu P; Wang R; Zhang L; Li T; Chen X; Wang A; Yang S; Wu Y; Yang H; Ji S
Arch Dermatol; 2005 Oct; 141(10):1285-93. PubMed ID: 16230567
[TBL] [Abstract][Full Text] [Related]
45. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma.
Seishima M; Oda M; Oyama Z; Yoshimura T; Yamazaki F; Aoki T; Nei M; Hashimoto T
Arch Dermatol; 2004 Dec; 140(12):1500-3. PubMed ID: 15611429
[TBL] [Abstract][Full Text] [Related]
46. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
47. Retrospective analysis of 45 cases of localized retroperitoneal Castleman disease from a single center.
Tang JQ; Chen HK; Wang X; Wang MY; Xiong Y; Wang H; Yang YM
Hepatobiliary Surg Nutr; 2020 Jun; 9(3):304-311. PubMed ID: 32509816
[TBL] [Abstract][Full Text] [Related]
48. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus.
Proby C; Fujii Y; Owaribe K; Nishikawa T; Amagai M
J Invest Dermatol; 1999 Feb; 112(2):153-6. PubMed ID: 9989789
[TBL] [Abstract][Full Text] [Related]
49. Paraneoplastic pemphigus as a presentation of acute myeloid leukemia: Early diagnosis and remission.
Siddiqui S; Bilal M; Otaibi Z; Bilimoria F; Patel N; Rossetti J
Hematol Oncol Stem Cell Ther; 2017 Sep; 10(3):155-160. PubMed ID: 27352260
[TBL] [Abstract][Full Text] [Related]
50. Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.
Tsuchisaka A; Numata S; Teye K; Natsuaki Y; Kawakami T; Takeda Y; Wang W; Ishikawa K; Goto M; Koga H; Sogame R; Ishii N; Takamori S; Hoshino T; Brandt O; Pas HH; Fujiwara S; Hashimoto T
J Invest Dermatol; 2016 Feb; 136(2):399-408. PubMed ID: 26802236
[TBL] [Abstract][Full Text] [Related]
51. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour.
Wolff H; Kunte C; Messer G; Rappersberger K; Held E; Löhrs U; Plewig G; Meurer M
Br J Dermatol; 1999 Feb; 140(2):313-6. PubMed ID: 10233229
[TBL] [Abstract][Full Text] [Related]
52. Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
Ohzono A; Sogame R; Li X; Teye K; Tsuchisaka A; Numata S; Koga H; Kawakami T; Tsuruta D; Ishii N; Hashimoto T
Br J Dermatol; 2015 Dec; 173(6):1447-52. PubMed ID: 26358412
[TBL] [Abstract][Full Text] [Related]
53. Paraneoplastic pemphigus caused by pre-existing stroma-rich variant of Castleman disease: from a pathologist's point of view.
Gwiti P; Melegh Z; Johnston S; Sutak J
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975839
[TBL] [Abstract][Full Text] [Related]
54. Bilateral lung transplantation for Castleman disease with end-stage bronchiolitis obliterans.
Yue B; Huang J; Jing L; Yu H; Wei D; Zhang J; Chen W; Chen J
Clin Transplant; 2022 Jan; 36(1):e14496. PubMed ID: 34590355
[TBL] [Abstract][Full Text] [Related]
55. Paraneoplastic pemphigus associated with chronic lymphocytic leukemia: A case report.
Jiang Q; Zhang BH
Medicine (Baltimore); 2017 Feb; 96(8):e6184. PubMed ID: 28225504
[TBL] [Abstract][Full Text] [Related]
56. Unicentric Castleman Disease.
Wong RSM
Hematol Oncol Clin North Am; 2018 Feb; 32(1):65-73. PubMed ID: 29157620
[TBL] [Abstract][Full Text] [Related]
57. Paraneoplastic pemphigus.
Zhu X; Zhang B
J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
[TBL] [Abstract][Full Text] [Related]
58. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
[TBL] [Abstract][Full Text] [Related]
59. Anti-α-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus.
Numata S; Teye K; Tsuruta D; Sogame R; Ishii N; Koga H; Natsuaki Y; Tsuchisaka A; Hamada T; Karashima T; Nakama T; Furumura M; Ohata C; Kawakami T; Schepens I; Borradori L; Hashimoto T
J Invest Dermatol; 2013 Jul; 133(7):1785-93. PubMed ID: 23407400
[TBL] [Abstract][Full Text] [Related]
60. A case of paraneoplastic pemphigus associated with Castleman's disease.
Zeng M; Zhang M; Hu W; Kong Q; Sang H; Xu X
An Bras Dermatol; 2013; 88(6 Suppl 1):11-4. PubMed ID: 24346868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
